News

Vocodia's Transition to OTCQB: A Strategic Move for Growth

Vocodia's Transition to OTCQB: A Strategic Move for Growth

Vocodia’s Delisting and What Comes Next

Vocodia Holdings Corp., a provider of AI software, is navigating a major shift. The company received a delisting notice from the Cboe BZX Exchange, with the change set to take effect soon. The decision covers the Company’s Common Stock (VHAI) and its Series A and Series B Warrants (VHAI+A and VHAI+B). While not the outcome the team had hoped for, Vocodia is using the moment to double down on strategy and move toward a planned listing on the OTCQB.

Leadership’s View on the Path Forward

Co-Founder and CEO Brian Podolak shared that, although the delisting is a setback, it creates room to focus. His message was steady: the Company will concentrate on delivering value for shareholders and clients while keeping its long-term plan intact. The aim remains sustainable growth, not short-term reactions.

Staying Focused on Growth

Podolak pointed to strong, still-untapped opportunities for Vocodia’s Digital Intelligent Sales Agent (DISA) technology platform. Moving from the CBOE to the OTCQB is framed as a practical step in the company’s evolution. The goal is to better align market presence with strategy—improving how customers engage with the product and how teams deliver sales solutions at scale.

What to Expect from the OTCQB Transition

Vocodia expects its common stock to begin trading on the OTC Markets Group platform shortly, continuing under the ticker symbol “VHAI.” The team is preparing for a smooth transition and is focused on staying accessible to businesses that want practical, deployable AI tools.

Compliance, Reporting, and Investor Updates

Even with the CBOE delisting, Vocodia will stay registered with the Securities and Exchange Commission and will continue meeting its reporting obligations under the Securities Exchange Act of 1934. Shareholders can expect ongoing, timely disclosures about financial results and key developments.

What Vocodia Builds

Vocodia develops AI software built for business use. At the center of its offerings is DISA—Digital Intelligent Sales Agents designed to scale customer interactions while controlling costs. Companies use these tools to automate and enhance sales and service conversations, reduce labor expenses where it makes sense, and improve the quality and consistency of each customer touchpoint.

Looking Ahead

As attention shifts to the expected OTCQB listing, Vocodia’s focus stays on applying AI to deepen customer engagement and strengthen relationship management. The company intends to keep iterating on its technology and execution so enterprise clients see tangible value in their day-to-day operations. It’s a turn in the road, not the end of it—and stakeholders are encouraged to stay close as the next chapter takes shape.

Frequently Asked Questions

Why was Vocodia notified of a delisting?

The Cboe BZX Exchange issued a delisting notification, prompting Vocodia to shift its focus to an OTCQB listing. The change reflects regulatory and listing considerations and the company’s decision to align with its strategic plan.

What does an OTCQB listing mean for investors?

The OTCQB is intended to better fit Vocodia’s current stage and goals, offering a public trading venue that can provide broader access to the market and potential investors while the company executes on its strategy.

How will Vocodia keep investors informed during this transition?

Vocodia will remain registered with the SEC and continue filing required reports under the Securities Exchange Act of 1934. Investors can expect regular, transparent updates on financials and material events.

What is DISA, and how can it help a business?

DISA stands for Digital Intelligent Sales Agents—AI-driven tools that handle parts of sales and customer service conversations. They’re built to scale outreach and support, reduce labor costs where appropriate, and improve consistency in customer interactions.

What are Vocodia’s near-term priorities for growth?

Vocodia plans to keep advancing its DISA technology, strengthen collaborations that support adoption, and pursue opportunities in the AI market that align with its long-term strategy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading